The genetic basis of multiple sclerosis: A model for MS susceptibility

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Goodin, Douglas S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; EUROPE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; MALE; MATHEMATICAL ANALYSIS; MODEL; MULTIPLE SCLEROSIS; NORTH AMERICA; PATHOGENESIS; PREDICTION; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGICAL MODEL; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; RISK FACTOR;

ALLELES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; MULTIPLE SCLEROSIS; PREVALENCE; RISK FACTORS;

EID: 77958518523     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-101     Document Type: Article

References (34)

1. Rothman KJ, Greenland S. Modern Epidemiology. 1998, Lippincott Williams & Wilkins, Philadelphia, 2.
2. Compston A, Confavreux C, Lassmann H, et al. McAlpine's Multiple Sclerosis 2006, Churchill Livingston, London, 4.
3. Ebers GC, Sadovnick AD, Risch NJ, . the Canadian Collaborative Study Group A genetic basis for familial aggregation in multiple sclerosis. Nature 1995, 377:150-151. 10.1038/377150a0, 7675080, the Canadian Collaborative Study Group.
4. Sadovnick AD, Ebers GC, Dyment DA, Risch NJ, . the Canadian Collaborative Study Group Evidence for genetic basis of multiple sclerosis. Lancet 1996, 347:1728-1730. 10.1016/S0140-6736(96)90807-7, 8656905, the Canadian Collaborative Study Group.
5. Robertson NP, Fraser M, Deans J, et al. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 1996, 119:449-455. 10.1093/brain/119.2.449, 8800940.
6. Sadovnick AD, Dircks A, Ebers GC, et al. Genetic counselling in multiple sclerosis: risks to sibs and children of affected individuals. Clin Genet 1999, 56:118-122. 10.1034/j.1399-0004.1999.560204.x, 10517247.
7. Compston A, Coles A. Multiple sclerosis. Lancet 2002, 359:1221-31. 10.1016/S0140-6736(02)08220-X, 11955556.
8. Ebers GC, Sadovnick AD, Dyment DA, et al. Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet 2004, 363:1773-1774. 10.1016/S0140-6736(04)16304-6, 15172777.
9. Nielsen NM, Westergaard T, Rostgaard K, et al. Familial risk of multiple sclerosis: A nationwide cohort study. Am J Epidemiol 2005, 162:774-778. 10.1093/aje/kwi280, 16120694.
10. Goodin DS. The Causal Cascade to Multiple Sclerosis: A model for MS pathogenesis. PLoS One 2009, 4(2):e4565. 10.1371/journal.pone.0004565, 2644781, 19242548.
11. Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC, . the Canadian Collaborative Study Group Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci (USA) 2003, 100:12877-12882. the Canadian Collaborative Study Group.
12. Dyment DA, Herrera BM, Cader Z, et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet. 2005, 14:2019-2026.
13. Hafler DA, Compston A, Sawcer S, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007, 357:851-862. 10.1056/NEJMoa073493, 17660530.
14. Ramagopalan SV, Anderson C, Sadovnick AD, Ebers GC. Genomewide study of multiple sclerosis. N Engl J Med 2007, 357:2199-2200. 10.1056/NEJMc072836, 18032773.
15. De Jager PL, Jia X, Wang J, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nature Genetics 2009, 41:776-782. 10.1038/ng.401, 2757648, 19525953.
16. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001, 22:117-139. 10.1007/s100720170011, 11603614.
17. Orton SM, Herrera BM, Yee IM, et al. the Canadian Collaborative Study Group Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol 2006, 5:932-936. 10.1016/S1474-4422(06)70581-6, 17052660, the Canadian Collaborative Study Group.
18. Murry TJ. The history of multiple sclerosis. Multiple Sclerosis: Diagnosis, Medical Management, and Rehabilitation 2000, 1-35. Demos Medical Publishing, New York, Burks JS, Johnson KP.
19. Kuusisto H, Kaprio J, Kinnunen E, et al. Concordance and heritability of multiple sclerosis in Finland: Study on a nationwide series of twins. Eur J Neurol 2008, 15:1106-1110. 10.1111/j.1468-1331.2008.02262.x, 18727671.
20. Koch-Henderson N. Multiple sclerosis in Scandinavia and Finland. Acta Neurol Scand 1995, 161:55-59.
21. Witte JS, Carlin JB, Hopper JL. Likelihood-Based Approach to Estimating Twin Concordance for Dichotomous Traits. Genetic Epidemiol 1999, 16:290-304.
22. Sadovnick AD, Ebers GC, Dyment DA, Risch NJ, . the Canadian Collaborative Study Group Evidence for genetic basis of multiple sclerosis. Lancet 1996, 347:1728-1730. 10.1016/S0140-6736(96)90807-7, 8656905, the Canadian Collaborative Study Group.
23. Ebers GC, Yee IML, Sandovnick AD, Duquette P, . the Canadian Collaborative Study Group Conjugal multiple sclerosis: Population-based prevalence and recurrence risks in offspring. Ann Neurol 2000, 48:927-931. 10.1002/1531-8249(200012)48:6<927::AID-ANA14>3.0.CO;2-F, 11117550, the Canadian Collaborative Study Group.
24. Ebers GC, Yee IML, Sandovnick AD, Duquette P, . the Canadian Collaborative Study Group Conjugal multiple sclerosis: Population-based prevalence and recurrence risks in offspring. Ann Neurol 2000, 48:927-931. 10.1002/1531-8249(200012)48:6<927::AID-ANA14>3.0.CO;2-F, 11117550, the Canadian Collaborative Study Group.
25. Sadovnick AD, Yee IML, Ebers GC, . the Canadian Collaborative Study Group Multiple sclerosis and birth order: A longitudinal cohort study. Lancet Neurol 2005, 4:611-617. 10.1016/S1474-4422(05)70170-8, 16168929, the Canadian Collaborative Study Group.
26. Bager P, Nielsen1 NM, Bihrmann K, et al. Sibship characteristics and risk of multiple sclerosis: A nationwide cohort study in Denmark. Am J Epidemiol 2006, 163:1112-1117. 10.1093/aje/kwj148, 16675539.
27. Dyment DA, Yee IML, Ebers GC, Sadovnick AD, . the Canadian Collaborative Study Group Multiple sclerosis in stepsiblings: Recurrence risk and ascertainment. J Neurol Neurosurg Psychiatry 2006, 77:258-259. 10.1136/jnnp.2005.063008, 2077589, 16421134, the Canadian Collaborative Study Group.
28. Oksenberg JR, Barcellos LF, Cree BA, et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004, 74:160-167. 10.1086/380997, 1181903, 14669136.
29. Dyment DA, Herrera BM, Cader MZ, et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 2005, 14:2019-2026. 10.1093/hmg/ddi206, 15930013.
30. Lincoln MR, Ramagopalan SV, Chao MJ, et al. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc Natl Acad Sci USA 2009, 106:7542-7547. 2678609, 19380721.
31. Baranzini SE, Mudge J, van Velkinburgh JC, et al. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature 2010, 464:1351-1356. 10.1038/nature08990, 2862593, 20428171.
32. Lindsey JW. Familial Recurrence Rates and Genetic Models of Multiple Sclerosis. Am J Med Genet. 2005, 135A:53-58.
33. Gregory SG, et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007, 39:1083-1091. 10.1038/ng2103, 17660817.
34. Zuvich RL, McCauley JL, Oksenberg JR, et al. Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Hum Genet 2010, 127:525-535. 10.1007/s00439-010-0789-4, 20112030.